Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_assertion type Assertion NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_head.
- NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_assertion description "[Using a proteomic-multiplexed analysis of the phosphotyrosine signaling together with antibody-based validation techniques, we identified several candidate molecules for RET (rearranged during transfection) tyrosine kinase receptor carrying mutations responsible for the multiple endocrine neoplasia type 2A and 2B (MEN2A and MEN2B) syndromes in two human medullary thyroid carcinoma (MTC) cell lines, TT and MZ-CRC-1, which express the RET-MEN2A and RET-MEN2B oncoproteins, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_provenance.
- NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_assertion evidence source_evidence_literature NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_provenance.
- NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_assertion SIO_000772 18756447 NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_provenance.
- NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_assertion wasDerivedFrom befree-20140225 NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_provenance.
- NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_assertion wasGeneratedBy ECO_0000203 NP467505.RAlgp1ORHl6uZY60IOnbOGgLA9IyghqY9iZIMxr5huWjs130_provenance.